Ingersoll-Rand Inc
Q4 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: −2.98%.
Did IR Beat Earnings? Q4 2025 Results
Ingersoll Rand closed out fiscal 2025 on a strong note, posting fourth-quarter revenue of $2.09 billion, up 10.1% year-over-year, and adjusted diluted EPS of $0.96, against a consensus estimate of $0.90, a beat of 6.57%. The results were driven by broad-based demand across its portfolio, underscored by 8% order growth to $1.95 billion and the fourth consecutive quarter of organic order growth within its Industrial Technologies and Services segment. Adjusted EBITDA reached $580.10 million, though margins ticked down 30 basis points to 27.7% as tariff-related headwinds and deliberate commercial investments tempered profitability gains. The company also repurchased $315.00 million in shares during the quarter, reflecting continued confidence in its capital position, which ended the year with $3.80 billion in liquidity. Institutional interest has remained notable as well, with Citigroup recently increasing its Ingersoll Rand stake. Looking to 2026, management guided for revenue growth of 2.5% to 4.5% and adjusted EPS of $3.45 to $3.57, representing growth of 3% to 7% at the midpoint.
- IRX (Ingersoll Rand Execution Excellence) driving strong operational performance
- Fourth consecutive quarter of organic order growth in IT&S segment
- P&ST Adjusted EBITDA margin expanded 280 basis points driven by IRX-fueled operational execution
- Organic revenue growth of 2.9% complemented by 4.0% acquisition contribution and 3.3% currency tailwind
- Total orders grew 8% to $1,952 million, reflecting positive demand trends
“Against the backdrop of a complex global environment, we delivered strong growth, earnings, and free cash flow, reflecting the resilience and execution strength of our portfolio.”
Ingersoll Rand CEO, on the earnings call
Forward Guidance & Outlook
For full-year 2026, Ingersoll Rand expects revenue growth of 2.5% to 4.5% (flat to 2% organic growth, ~1% currency tailwind, ~1.5% M&A contribution), Adjusted EBITDA of $2,130 million to $2,190 million (up 2% to 5% year-over-year), Adjusted EPS of $3.45 to $3.57 (up 3% to 7%, +5% at midpoint), and free cash flow to adjusted net income conversion of approximately 95%. Assumptions include corporate costs of ~$170 million, net interest expense of ~$230 million, adjusted tax rate of ~23%, and share count of ~394 million. Revenue phasing is expected at 1H 48% / 2H 52%, and Adjusted EBITDA phasing at 1H 46% / 2H 54%.
IR YoY Financials
IR Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.